{"id":"placebo-of-ad-208","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL1165764","moleculeType":"Protein","molecularWeight":"1056.23"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"As a placebo, AD-208 does not interact with any biological systems or receptors. It is used as a control in clinical trials to compare the effects of the active treatment.","oneSentence":"This is a placebo, meaning it has no active pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:28:02.916Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT04825561","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of AD-208","status":"COMPLETED","sponsor":"Addpharma Inc.","startDate":"2021-06-09","conditions":"Androgenetic Alopecia","enrollment":139}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"placebo of AD-208","genericName":"placebo of AD-208","companyName":"Addpharma Inc.","companyId":"addpharma-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}